Corporate Income Tax - Addition Modification - Direct-to-Consumer Pharmaceutical Advertising

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 3 Sponsors

Mar 5, 2026 · Senate

Hearing 3/11 at 1:00 p.m.

Mar 4, 2026 · Senate

Rereferred to Budget and Taxation

Feb 15, 2026 · Senate

First Reading Senate Rules

PASSAGE PROBABILITY

2.2% Unlikely

Why this number

Stage base In Committee — base rate 29%, measured from MD's completed sessions
Momentum -5 27/100 from the pace of recorded action
Time since last action -22 221 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.